List of Excipients in API sargramostim
✉ Email this page to a colleague
Detailed excipient profiles for sargramostim
Excipient focus: BENZYL ALCOHOL
sargramostim drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | sargramostim | 0024-5844 |
| >Company | >Ingredient | >NDC |
sargramostim drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Partner Therapeutics Inc | sargramostim | 71837-5843 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
sargramostim drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Partner Therapeutics Inc | sargramostim | 71837-5843 |
| >Company | >Ingredient | >NDC |
sargramostim drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | sargramostim | 0024-5844 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
sargramostim drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | sargramostim | 0024-5844 |
| Partner Therapeutics Inc | sargramostim | 71837-5843 |
| >Company | >Ingredient | >NDC |
sargramostim drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
sargramostim drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | sargramostim | 0024-5844 |
| Partner Therapeutics Inc | sargramostim | 71837-5843 |
| >Company | >Ingredient | >NDC |
sargramostim drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
sargramostim drug variants containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | sargramostim | 0024-5844 |
| Partner Therapeutics Inc | sargramostim | 71837-5843 |
| >Company | >Ingredient | >NDC |
sargramostim drug variants not containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
sargramostim drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Partner Therapeutics Inc | sargramostim | 71837-5843 |
| >Company | >Ingredient | >NDC |
sargramostim drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | sargramostim | 0024-5844 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
